Wellmedr vs MedVi: Pricing, meds, and support compared
Wellmedr vs MedVi: quick verdict and what to watch
Wellmedr vs MedVi differs most on starting price, product selection, and support model. Quick verdict: Wellmedr emphasizes low starting plans and lifetime locked-in pricing while MedVi promotes a $179 promotional first month with 24/7 certified medical support. This comparison uses only the supplied facts and preserves each provider’s qualifiers.
See Wellmedr plans starting at $89/mo
Five key differences to compare
Direct comparison centers on five supported differences: starting price and promotions, medication options, pricing guarantees and ongoing cost, clinician and support model, and regulatory status of compounded drugs. Each section below compares Wellmedr and MedVi using only the supplied evidence.
1) Starting price and promotional structure
Wellmedr advertises GLP-1 plans starting at $89 per month and highlights specific sale messaging such as Labor Day Sale: lock in offers described in the source. MedVi lists a winter promotional price of $179 for the first month including fast, free shipping, but the source notes that ongoing standalone months can cost more. The supplied evidence shows Wellmedr’s plan language includes semaglutide options starting at $49 a month for some plans and tirzepatide starting at $89, while MedVi emphasizes a $179 first month promo with later higher refill pricing documented in the source.
View MedVi promotional $179 first month
2) Medication selection and program scope
Wellmedr’s source lists semaglutide and tirzepatide offers and also mentions branded items such as Ozempic and Zepbound with specific starting prices in the landing evidence. MedVi’s source focuses on compounded semaglutide only and explicitly notes it offers semaglutide and not tirzepatide, and that compounded semaglutide uses the same active ingredient as Ozempic and Wegovy according to the source. If medication variety matters, Wellmedr shows multiple GLP-1 ingredients referenced while MedVi centers on semaglutide.
3) Pricing guarantees and plan commitments
The Wellmedr evidence repeatedly highlights lifetime locked-in pricing and statements such as No dose-based price increases and New Customer Offer: $150 off for Life. The source also includes a money back guarantee claim and a 90 day refund claim in the captured landing-page evidence. MedVi’s source indicates a promotional first-month price and clarifies that refills are locked in at a higher ongoing price in the source; it also notes no contract for the first month and an available three-month plan at $649 as described in the provided material. The two providers therefore present contrasting pricing frameworks in the source.
Lock a Wellmedr pricing option
4) Clinician oversight and support
Both platforms require clinician review and approval per the supplied evidence. The MedVi source emphasizes a simple online intake, no clinic visits, an OpenLoop Health clinician review after checkout, and 24/7 certified medical support. Wellmedr’s source states All treatment plans require medical evaluation and clinician approval and mentions same-day review plus free overnight shipping. So MedVi highlights round the clock certified support while Wellmedr highlights same-day review and shipping commitments in the provided material.
5) Compounded medication regulatory notes and safety language
Both sources include regulatory language about compounded medications. Wellmedr’s evidence explicitly states WellMedr offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and that compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy. MedVi’s source likewise notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality while adding that compounded GLP-1s are produced in FDA-regulated facilities but the medications themselves are not FDA-approved. Each provider’s statements are preserved exactly as presented.
Comparison table: direct side by side
| Criteria | Wellmedr | MedVi |
|---|---|---|
| Starting price | Semaglutide from $89/mo; semaglutide listed as starting at $49/mo in landing evidence | Promotional first month $179 with fast, free shipping |
| Medication options | Semaglutide and tirzepatide mentioned; branded items listed in evidence | Compounded semaglutide only per source |
| Pricing guarantees | Lifetime locked-in pricing; No dose-based price increases; money back claim in landing evidence | First month promo then higher refill pricing; three-month plan described |
| Support and clinician model | Same-day review and free overnight shipping; clinician approval required | No clinic visits; simple online intake; 24/7 certified medical support; clinician review after checkout |
| Regulatory note | Compounded medications not evaluated by FDA for safety or efficacy; supplied language preserved | Compounded medications not FDA-approved or reviewed by FDA for safety, effectiveness or quality |
How to choose: final guidance
Choose Wellmedr if you prioritize lower advertised starting plans, lifetime locked-in pricing language, or access to both semaglutide and tirzepatide as shown in the source. Choose MedVi if you prefer a simple online process with no clinic visits and round the clock certified medical support plus a documented promotional first-month price of $179 in the provided material.
Start MedVi with the $179 promo
Review Wellmedr offers and shipping terms
Closing note
This comparison focused only on supplied facts for Wellmedr vs MedVi. Confirm eligibility, medication specifics, ongoing costs, clinician review, and state availability directly with each provider before enrolling. Compounded medication regulatory notices and safety language above are preserved from the sources.